Enzalutamide alone had a minimal effect under the tested dosing conditions (Fig. 7i, Supplementary Fig. 13), while NME2 knockdown (with Doxycycline in drinking water) re-sensitized tumors to Enzalutamide, with an average tumor growth inhibition of 62%. Here, NME2 is linked to neoplasm.